{
    "code": "60001201",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001201",
    "time": "2022-12-30 05:47:59",
    "許可證字號": "衛部菌疫輸字第001201號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/11\/10",
    "發證日期": "111\/11\/10",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000120107",
    "中文品名": "芮寶興凍晶注射劑",
    "英文品名": "Reblozyl powder for solution for injection",
    "適應症": "用於治療IPSS-R分級為非常低度至中度風險(very low to intermediate risk)且具有ring sideroblasts之骨髓增生不良症候群(myelodysplastic syndrome)所導致的輸血依賴型貧血成人病人，病人需對紅血球生成素基礎療法(erythropoietin-based therapy)治療效果不佳或是不適用紅血球生成素基礎療法",
    "劑型": "243凍晶注射劑",
    "包裝": "25毫克玻璃小瓶裝；100支以下盒裝 75毫克玻璃小瓶裝；100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分",
    "監視期限": "116\/11\/10",
    "主成分略述": "luspatercept",
    "限制項目": "02輸　入 5G小兒\/少數嚴重疾病藥品認定",
    "申請商名稱": "1404501100  台灣必治妥施貴寶股份有限公司",
    "申請商地址": "臺北市松山區健康路156號4樓、5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIT9099000  PATHEON ITALIA S.P.A.",
            "製造廠廠址": "VIALE G.B. STUCCHI, 110-20900 MONZA (MB), ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "成品及包裝廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FBE0120000  SHARP PACKAGING SOLUTIONS",
            "製造廠廠址": "KLOCKNERSTRAAT 1, 3930 HAMONT-ACHEL, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FUS0785200  BIOGEN MA INC.",
            "製造廠廠址": "5000 DAVIS DR, RESEARCH TRIANGLE PARK, NC 27709, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1600001800",
            "成分名稱": "luspatercept",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1600001800",
            "成分名稱": "luspatercept",
            "含量描述": "",
            "含量": "75.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Reblozyl MDS_中文仿單_1116-111-11-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001201&Seq=001&Type=9"
        }
    ]
}